| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.086 | 0.01 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.02 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.29 | 0.02 |